Table 1.
Drug name | Classification | Referencea |
---|---|---|
Afatinib | 0 | Drugs@FDA and literature search |
Alendronate | 0 | Drugs@FDA and literature search |
Amiodarone | 1 | Drugs@FDA |
Axitinib | 1 | Drugs@FDA |
Bosutinib | 0 | Drugs@FDA and literature search |
Cefuroxime | 0 | Drugs@FDA and literature search |
Crizotinib | 0 | Drugs@FDA and literature search |
Cyclosporine | 0 | Drugs@FDA and literature search |
Cytarabine | 1 | NIH DailyMed |
Dasatinib | 1 | Drugs@FDA |
Diclofenac | 1 | Drugs@FDA |
Domperidone | 0a | Not approved by FDA |
Doxorubicin | 1 | Drugs@FDA |
Diethylpropion | 0 | Drugs@FDA and literature search |
Erlotinib | 0 | Drugs@FDA and literature search |
Gefitinib | 0 | Drugs@FDA and literature search |
Imatinib | 1 | Drugs@FDA |
Lapatinib | 0 | Drugs@FDA |
Methotrexate | 0 | Drugs@FDA and literature search |
Olmesartan | 0 | Drugs@FDA and literature search |
Paroxetine | 1 | Drugs@FDA |
Ponatinib | 1 | Drugs@FDA |
Regorafenib | 0 | Drugs@FDA and literature search |
Ruxolitinib | 0 | Drugs@FDA and literature search |
Sorafenib | 1 | Drugs@FDA |
Sunitinib | 1 | Drugs@FDA |
Tofacitinib | 0 | Drugs@FDA and literature search |
Trametinib | 1 | Drugs@FDA and literature search |
Ursodeoxycholic acid | 0 | Drugs@FDA and literature search |
Vandetanib | 1 | Drugs@FDA |
Vemurafenib | 0 | Drugs@FDA and literature search |
FDA, US Food and Drug Administration; NIH, National Institutes of Health.
Note: Toxic: 1 (clinical incidence ≥ 0.1%), and nontoxic: 0 (clinical incidence <0.1%). https://dailymed.nlm.nih.gov/dailymed/
Domperidone was profiled by Drug Toxicity Signature Generation Center (DtoxS) and toxicity information was from http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/domperidone-eng.php.